NCT02834013 2026-06-03Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting798 enrolled
NCT04657068 2026-03-18A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsArtios Pharma LtdPhase 1/2 Recruiting442 enrolled